Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles

被引：0
|
作者：
Xingyang Yi
Qiang Zhou
Chun Wang
Jing Lin
Zhenxiao Chai
机构：
[1] People’s Hospital of Deyang City,Department of Neurology
[2] The Third Affiliated Hospital of Wenzhou Medical University,Department of Neurology
来源：
Journal of Neurology | 2018年 / 265卷
关键词：
Early neurological deterioration; Ischemic stroke; Clopidogrel; polymorphism; Dual antiplatelet therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2396 / 2403
页数：7
相关论文
共 50 条
  • [1] Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Yi, Xingyang
    Zhou, Qiang
    Wang, Chun
    Lin, Jing
    Chai, Zhenxiao
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2396 - 2403
  • [2] Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Lin, Jing
    Han, Zhao
    Wang, Chun
    Yi, Xingyang
    Chai, Zhenxiao
    Zhou, Qiang
    Huang, Ruyue
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1131 - 1140
  • [3] Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Jing Lin
    Zhao Han
    Chun Wang
    Xingyang Yi
    Zhenxiao Chai
    Qiang Zhou
    Ruyue Huang
    European Journal of Clinical Pharmacology, 2018, 74 : 1131 - 1140
  • [4] Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2
    Yi, Xingyang
    Han, Zhao
    Zhou, Qiang
    Cheng, Wen
    Lin, Jing
    Wang, Chun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (01) : 55 - 62
  • [5] Carriage of Reduced-Function CYP2C19 Allele Among Patients Treated With Clopidogrel
    Osnabrugge, Ruben L. J.
    Kappetein, A. Pieter
    Janssens, A. Cecile J. W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05): : 467 - 468
  • [6] Carriage of Reduced-Function CYP2C19 Allele Among Patients Treated With Clopidogrel Reply
    Mega, Jessica L.
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05): : 468 - 468
  • [7] CYP2C19 Genotype and Early Ischemic Lesion Recurrence in Stroke Patients Treated with Clopidogrel
    Jeong, Tae-Dong
    Kim, Seung Min
    Kim, Hyo Jin
    Lee, Woochang
    Kwon, Sun U.
    Min, Won-Ki
    Kang, Dong-Wha
    Chun, Sail
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (02): : 440 - 446
  • [8] Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant A Limited Piece of the Overall Therapeutic Puzzle
    Fuster, Valentin
    Sweeny, Joseph M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16): : 1839 - 1840
  • [9] Clopidogrel increases risk of MACE in patients with CYP2C19 LoF alleles
    Reactions Weekly, 2025, 2047 (1) : 7 - 7
  • [10] Review: Reduced function CYP2C19 genotypes may increase risk for stent clots in patients receiving clopidogrel
    Wang, Tracy Y.
    Granger, Christopher B.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (12)
12345